Standard BioTools Inc.
LAB | NASDAQ
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Market Data
Market Cap $301.35M
Enterprise Value $-158.21M
Beta 1.37
Average Volume 2.98M
Shares Outstanding (Diluted) 390.88M
Shares Change YoY 2.73%
Institutional Ownership 76.57%
Exchange NASDAQ
ISIN US34385P1084
Price Performance
Price Change 1M 10.4%
Price Change 3M -6.6%
Price Change 6M -23.1%
Price Change YTD -41.7%
Price Change 1Y -47.1%
Price Change 3Y -73.4%
Price Change 5Y -88.8%
1M CAGR (ann.) -3.8%
1Y CAGR (ann.) -43.0%
5Y CAGR (ann.) -35.3%
All-Time CAGR -17.0%
Valuation
PE Ratio -3.22
Forward PE N/A
PEG Ratio -0.46
Forward PEG -0.06
PS Ratio 3.43
Forward PS 3.50
PB Ratio 0.54
P/FCF Ratio -2.24
P/Adj. FCF Ratio -1.76
P/OCF Ratio -3.52
EV/Sales -1.87
EV/EBIT 1.60
EV/EBITDA 1.72
EV/FCF 1.22
Earnings Yield -31.1%
FCF Yield -44.7%
Adj. FCF Yield -56.7%
Financial Health
Net Cash $476.42M
Total Debt $28.09M
Cash & Short-Term Investments $476.72M
Total Assets $627.22M
Current Ratio 9.10
Quick Ratio 8.80
Debt / Equity Ratio 0.05
Debt / EBITDA -0.31
Debt / FCF -0.22
OCF / Debt -4.52
Interest Coverage -5,346.33
Altman Z-Score -0.02
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 49.1%
Operating Profit Margin -94.8%
EBITDA Margin -108.6%
Net Profit Margin -103.3%
FCF Margin -153.4%
Adj. FCF Margin -194.7%
SBC / Revenue 30.9%
SBC Impact (per share) -27.0%
Returns
Return on Assets -13.9%
Return on Equity -18.2%
Return on Invested Capital -8.3%
Return on Capital Employed -14.1%
Return on Tangible Assets -13.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -7.1%
Revenue CAGR 5Y -10.6%
Revenue CAGR 10Y -3.1%
EPS CAGR 3Y 69.9%
EPS CAGR 5Y 48.6%
EPS CAGR 10Y 14.9%
FCF CAGR 3Y 0.4%
FCF CAGR 5Y -16.8%
FCF CAGR 10Y -17.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 11.6%
Revenue Growth Next 3Y 1.9%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.02
EPS Growth Est (next Q) -77.8%
Revenue Est (next Q) $18.8M
Revenue Growth Est (next Q) -3.9%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3.25
Price Target Upside 339.2%
Cash Flow
Operating Cash Flow $-126.9M
Free Cash Flow $-129.75M
Adj. Free Cash Flow $-164.73M
FCF Per Share -$0.21
OCF Per Share -$0.21
OCF/S Ratio -94.9%
Income Statement
Revenue $84.6M
Gross Profit $41.57M
Operating Income $-80.2M
EBITDA $-91.9M
Net Income $-87.38M
EPS (Diluted) -$0.23
Revenue / Employee $218.6K
Profit / Employee $-225.8K
Employees 387
Add to Watchlist
Select watchlists to add or remove LAB